Literature DB >> 16195237

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

Shanbeh Zienolddiny1, Daniele Campa, Helge Lind, David Ryberg, Vidar Skaug, Lodve Stangeland, David H Phillips, Federico Canzian, Aage Haugen.   

Abstract

Lung cancer is a leading cause of cancer mortality with an inter-individual difference in susceptibility to the disease. The inheritance of low-efficiency genotypes involved in DNA repair and replication may contribute to the difference in susceptibility. We investigated 44 single nucleotide polymorphisms (SNPs) in 20 DNA repair genes including nucleotide excision repair (NER) genes XPA, ERCC1, ERCC2/XPD, ERCC4/XPF and ERCC5/XPG; base excision repair (BER) genes APE1/APEX, OGG1, MPG, XRCC1, PCNA, POLB, POLiota, LIG3 and EXO1; double-strand break repair (DSB-R) genes XRCC2, XRCC3, XRCC9, NBS1 and ATR; and direct damage reversal (DR) gene MGMT/AGT. The study included 343 non-small cell lung cancer (NSCLC) cases and 413 controls from Norwegian general population. Our results indicate that SNPs in the NER genes ERCC1 (Asn118Asn, 15310G>C, 8902G>T), XPA (-4G>A), ERCC2/XPD (Lys751Gln) and ERCC5/XPD (His46His); the BER genes APE1/APEX (Ile64Val), OGG1 (Ser326Cys), PCNA (1876A>G) and XRCC1 (Arg194Trp, Arg280His, Arg399Gln); and the DSB-R genes ATR (Thr211Met), NBS1 (Glu185Gln), XRCC2 (Arg188His) and XRCC9 (Thr297Ile) modulate NSCLC risk. The level of polycyclic aromatic hydrocarbon-DNA (PAH-DNA) adducts in normal lung tissue from 211 patients was analysed. The variant alleles of XRCC1(Arg280His), XRCC1 (Arg399Gln), ERCC1(G8092T), ERCC5(His46His) and MGMT/AGT(Lys178Arg) were more frequent in patients with PAH-DNA adduct levels lower than the mean whereas the XRCC1(Arg194Trp) variant was more frequent in cases with higher adduct levels than the mean.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195237     DOI: 10.1093/carcin/bgi232

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  159 in total

1.  Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism.

Authors:  Sheetal Sharma; Bibha Choudhary; Sathees C Raghavan
Journal:  Cell Mol Life Sci       Date:  2010-08-03       Impact factor: 9.261

2.  Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Therese Truong; Rayjean J Hung; Christopher I Amos; Xifeng Wu; Heike Bickeböller; Albert Rosenberger; Wiebke Sauter; Thomas Illig; H-Erich Wichmann; Angela Risch; Hendrik Dienemann; Rudolph Kaaks; Ping Yang; Ruoxiang Jiang; John K Wiencke; Margaret Wrensch; Helen Hansen; Karl T Kelsey; Keitaro Matsuo; Kazuo Tajima; Ann G Schwartz; Angie Wenzlaff; Adeline Seow; Chen Ying; Andrea Staratschek-Jox; Peter Nürnberg; Erich Stoelben; Jürgen Wolf; Philip Lazarus; Joshua E Muscat; Carla J Gallagher; Shanbeh Zienolddiny; Aage Haugen; Henricus F M van der Heijden; Lambertus A Kiemeney; Dolores Isla; Jose Ignacio Mayordomo; Thorunn Rafnar; Kari Stefansson; Zuo-Feng Zhang; Shen-Chih Chang; Jin Hee Kim; Yun-Chul Hong; Eric J Duell; Angeline S Andrew; Flavio Lejbkowicz; Gad Rennert; Heiko Müller; Hermann Brenner; Loïc Le Marchand; Simone Benhamou; Christine Bouchardy; M Dawn Teare; Xiaoyan Xue; John McLaughlin; Geoffrey Liu; James D McKay; Paul Brennan; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2010-06-14       Impact factor: 13.506

3.  APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.

Authors:  Ya-Nan Ji; Ping Zhan; Jing Wang; Li-Xin Qiu; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

4.  XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies.

Authors:  Liping Dai; Fujiao Duan; Peng Wang; Chunhua Song; Kaijuan Wang; Jianying Zhang
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

5.  Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Wenlong Zhai; Ruo Feng; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-04-03

6.  XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.

Authors:  Jun Liu; Zhen Zhang; Xiao-Lin Cao; Da-Peng Lei; Zhong-Qiu Wang; Tong Jin; Xin-Liang Pan
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

7.  Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools.

Authors:  Yong Zhu; Aaron Hoffman; Xifeng Wu; Heping Zhang; Yawei Zhang; Derek Leaderer; Tongzhang Zheng
Journal:  Mutat Res       Date:  2007-11-26       Impact factor: 2.433

8.  APE1 Asp148Glu polymorphism and lung cancer susceptibility.

Authors:  Liyun Cai; Yingjv Fu; Yuanyue Zhang
Journal:  Tumour Biol       Date:  2014-02-13

9.  DNA repair gene polymorphisms and risk of pancreatic cancer.

Authors:  Donghui Li; Hideo Suzuki; Bingrong Liu; Jeffrey Morris; Jun Liu; Taro Okazaki; Yanan Li; Ping Chang; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

10.  Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer.

Authors:  Taro Okazaki; Li Jiao; Ping Chang; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.